Using a single inhaler device containing an inhaled corticosteroid plus a long-acting β-adrenoceptor agonist is a practical approach in patients with moderate to severe asthma

被引：0
|
作者：
机构：
来源：
Drugs & Therapy Perspectives | 2008年 / 24卷 / 3期
关键词：
Asthma; Salmeterol; Formoterol; Nedocromil; Zafirlukast;
D O I：
10.2165/00042310-200824030-00003
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：9 / 11
页数：2
相关论文
共 50 条
  • [21] Combination therapy with a long-acting β2-agonist and an inhaled corticosteroid as initial maintenance treatment in asthma
    Lee, DKC
    Currie, GP
    Lipworth, BJ
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2005, 94 (03) : 410 - 411
  • [22] Long-Acting Beta2 Adrenoceptor Agonist Suppresses Fibrocytes In Non- Severe Asthma But Not In Severe Asthma
    Lo, C. -Y.
    Bhavsar, P. K.
    Michaeloudes, C.
    Chung, K. F.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [23] Inhaled Corticosteroid/Long-Acting β2-Agonist Combination Therapy for Asthma: Attitudes of Specialists in Europe
    Bousquet, Jean
    Winchester, Chris
    Papi, Alberto
    Virchow, J. Christian
    Haughney, John
    Costa, David
    Usmani, Omar
    Bjermer, Leif
    Price, David
    INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 2012, 157 (03) : 303 - 310
  • [24] Inhaled corticosteroid and long-acting β2-agonist pharmacological profiles: effective asthma therapy in practice
    Tamm, Michael
    Richards, David H.
    Beghe, Bianca
    Fabbri, Leonardo
    RESPIRATORY MEDICINE, 2012, 106 : S9 - S19
  • [25] The Impact of Nonadherence to Inhaled Long-Acting β2-Adrenoceptor Agonist/Corticosteroid Combination Therapy on Healthcare Costs in Difficult-to-Control Asthma
    Ciaran O’Neill
    Jacqui Gamble
    John T. Lindsay
    Liam G. Heaney
    Pharmaceutical Medicine, 2011, 25 (6) : 379 - 385
  • [26] Long-acting muscarinic antagonist versus long-acting β2 agonist/corticosteroid for moderate to severe chronic obstructive pulmonary disease patients: Exacerbation risk assessment
    Yang, Sheau-Ning
    Ko, Hsin-Kuo
    Hsiao, Yi-Han
    Su, Kang-Cheng
    Chang, Yuh-Lih
    Huang, Hsin-Yi
    Perng, Diahn-Warng
    Chung, Mei-Ing
    JOURNAL OF THE CHINESE MEDICAL ASSOCIATION, 2019, 82 (06) : 488 - 494
  • [27] COST-EFFECTIVENESS OF A NEW SINGLE INHALER TRIPLE THERAPY VERSUS A DUAL INHALED CORTICOSTEROID PLUS LONG-ACTING BETA AGONIST IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD) IN SPAIN
    Benjamin, N.
    Huerta, A.
    Biswas, C.
    Schroeder, M.
    Whalen, J.
    Izquierdo Alonso, J. L.
    Soler Cataluna, J. J.
    Riesco Miranda, J. A.
    Martin, A.
    Atienza, L.
    Ismaila, A.
    VALUE IN HEALTH, 2018, 21 : S3 - S3
  • [28] Adherence to Inhaled Corticosteroid (ICS) and Long Acting Beta-Adrenoceptor Agonist (LABA) Therapy in Severe Asthma Clinical Trials: A Systematic Review
    Mokoka, M. C.
    Mc Donnell, M. J.
    Cormican, S.
    Boland, F.
    Doyle, F.
    Costello, R. W.
    IRISH JOURNAL OF MEDICAL SCIENCE, 2016, 185 : S455 - S455
  • [29] Long-acting β-agonist treatment in patients with persistent asthma already receiving inhaled corticosteroids
    Hancox, RJ
    Taylor, DR
    BIODRUGS, 2001, 15 (01) : 11 - 24
  • [30] Long-Acting β- Agonist Treatment in Patients with Persistent Asthma Already Receiving Inhaled Corticosteroids
    Robert J. Hancox
    D. Robin Taylor
    BioDrugs, 2001, 15 : 11 - 24
12345